MEDIA ADVISORY: BIO VentureForum 2001 Slated for October 3 and 4, 2001

  • Recommend
  • Tweet
  • Print
  • Email
WHAT: The Biotechnology Industry Organization (BIO), in partnership with the National Venture Capital Association, NASDAQ, the Technology Council of Maryland, and the Washington Business Journal, will host BIO VentureForum October 3-4, 2001, in Washington, D.C. BIO VentureForum 2001 will showcase 94 promising health-care venture opportunities from across the world.
WHEN: Wednesday, October 3, 8:00am - 5:00pm
Thursday, October 4, 8:00am - 5:00pm
WHERE: Hilton Washington & Towers
1919 Connecticut Ave., N.W.
Washington, D.C.


HIGHLIGHTS
Wednesday, October 3
8:30am Welcoming Remarks by Carl B. Feldbaum, president of BIO, and Dyan Brasington, president of the Technology Council of Maryland
Opening Keynote Addresses presented by Rita R. Colwell, Ph.D., director, National Science Foundation, and William A. Haseltine, Ph.D., chairman and CEO, Human Genome Sciences Inc.
10:10am Company Presentations
12:00pm Scientist to CEO - Three Success Stories, with panel members Judith A. Britz, Ph.D., president and CEO, Cylex, Inc.; Wayne T. Hockmeyer, Ph.D., chairman, MedImmune; and John W. Holaday, Ph.D., chairman and CEO, EntreMed, Inc.
1:30pm Company Presentations
4:15pm Evening Keynote Address by M. James Barrett, general partner, New Enterprise Associates, and David Wield, IV, executive vice president, Corporate Client Division, The Nasdaq Stock Market, Inc.

Thursday, October 4, 2001
8:15am Opening Remarks by Morrie Ruffin, vice president for Business Development and Emerging Companies at BIO, and Jennie Hunter-Cevera, Ph.D., president of the University of Maryland Biotechnology Institute.
8:30am The Venture Capital View, moderated by Steven L. Meltzer, senior partner, ShawPittman LLP; panel members are from Domain Associates LLC, SG Cowen Securities, Perseus-Soros Biopharmaceutical Fund, Venrock Associates, Alta Partners, and the National Venture Capital Association
10:10am Company Presentations
12:00pm Luncheon Keynote Address - Scott Morrison, National Director of Life Sciences, Ernst & Young LLP, will discuss the state of the industry and introduce Focus on Fundamentals: The Biotechnology Report, Ernst & Young's 15th Annual Review.
1:10pm Company Presentations


About BIO
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50
U.S. states and 33 other nations. BIO members are involved in the research and
development of health-care, agricultural, industrial and environmental biotechnology
products. For more information, please visit www.bio.org.

About TCM
The Technology Council of Maryland is a 501c membership consortium
of more than 800 high technology firms, government laboratories, higher education
institutions and technology business service firms. Its mission includes developing links between member organizations, serving as a uniting voice for technology in Maryland, developing and enhancing the region's technology workforce, encouraging
entrepreneurship, and advocating for public support and understanding of technology
industry issues. For more information, please visit www.mdhitech.org

# # #

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.